IFNA1 and neoplasm: Parlato et al. investigated IFNα-conditioned dendritic cells for use as a therapeutic vaccine in combinations with chemotherapy drug, romidepsin.68 Migration channels connected the tumour and immune chambers to allow analysis of DC migration, phagocytosis and cell–cell interactions, aiming to mimic in vivo DC crossing of the endothelial barrier.